The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

In-stent CTOs: same story with a different conclusion?

EuroIntervention 2021;17:e611-e612. DOI: 10.4244/EIJV17I8A109

1. St George's, University of London, London, United Kingdom; 2. St George's University Hospitals NHS Foundation Trust, London, United Kingdom
Chronic total occlusion (CTO) is a common finding, identified in around 20% of patients with coronary artery disease (CAD)1. There has been a recent global growth of procedures, with increasing rates of success, aided by advances in technology and successful application of systematic approaches such as the hybrid algorithm. As the number of patients undergoing revascularisation for non-occlusive CAD continues to rise, occlusive in-stent restenosis (ISR-CTO) is also likely to increase. Although bare metal stents (BMS) have been completely superseded by drug-eluting stents (DES), which are less prone to ISR, in the last decade, ISR-CTO still comprises a significant proportion of ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Early spontaneous reperfusion after acute myocardial infarction: true association with plaque phenotype or simple clinical observation?